Dynavax Technologies reported $4.47M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Adma Biologics ADMA:US $ -18.9M 0.52M
Agenus AGEN:US $ -83.29M 29.61M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Amgen AMGN:US $ 464M 1182M
AstraZeneca AZN:LN 550M 1011M
Astrazeneca AZN:US $ 550M 1011M
Biogen BIIB:US $ 448.5M 38.3M
Biomarin Pharmaceutical BMRN:US $ 12.94M 4.43M
BioSpecifics Technologies BSTC:US 5.39 5.27
Bristol Myers Squibb BMY:US $ 1055M 966M
Chimerix CMRX:US $ -17.76M 79.65M
Dynavax Technologies DVAX:US $ 4.47M 3.58M
Gilead Sciences GILD:US $ 1522M 207M
Glaxosmithkline GSK:US $ 1395M 322M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Idera Pharmaceuticals IDRA:US $ -7.56M 123.3M
Merk MRK:US $ 1545M 1634M
Minerva Neurosciences NERV:US $ -10.59M 1.78M
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Novartis NOVN:VX SF 2896M 837M
Pfizer PFE:US $ 5564M 686M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Tg Therapeutics TGTX:US $ -78.5M 12.13M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M